The Micrurus genus is the American representative of Elapidae family. Micrurus spixii is endemic of South America and northern states of Brazil. Elapidic venoms contain neurotoxins that promote curare-mimetic neuromuscular blockage. In this study, biochemical and functional characterizations of M. spixii crude venom were performed and a new neurotoxic phospholipase A 2 called MsPLA 2 -I was isolated. M. spixii crude venom caused severe swelling in the legs of tested mice and significant release of creatine kinase (CK) showing its myotoxic activity. Leishmanicidal activity against Leishmania amazonensis (IC 50 1.24 mg/ mL) was also observed, along with antiplasmodial activity against Plasmodium falciparum, which are unprecedented for Micrurus venoms. MsPLA 2 -I with a Mr 12,809.4 Da was isolated from the crude venom of M. spixii. The N-terminal sequencing of a fragment of 60 amino acids showed 80% similarity with another PLA 2 from Micrurus altirostris. This toxin and the crude venom showed phospholipase activity. In a mouse phrenic nerve-diaphragm preparation, M. spixii venom and MsPLA 2 -I induced the blockage of both direct and indirect twitches. While the venom presented a pronounced myotoxic activity, MsPLA 2 -I expressed a summation of neurotoxic activity. The results of this study make M. spixii crude venom promising compounds in the exploration of molecules with microbicidal potential.
In the Americas, the snakes known as coral snakes or corals are those belonging to the genus Leptomicrurus, Micrurus and Micruroides, which are representatives of the Elapidae family in this part of the world (Urdaneta et al., 2004; Dal Belo et al., 2005) . This genus presents a greater variability of species in the areas surrounding the equator (Salazar et al., 2011) . Micrurus spixii (Fig. 1A) is endemic in five countries of South America: Brazil, Colombia, Venezuela, Bolivia and Peru. In Brazil M. spixii is endemic in the states of Acre, Amazonas, Mato Grosso, Par a, Rondônia and the Micrurus genus has about 27 other species dispersed throughout the country (Bernarde and Gomes, 2012; Ciscotto et al., 2011) (Fig. 1B) .
The genus Micrurus is responsible for 0.4% of the accidents and the mortality coefficient is 0.63% having relevant importance in Brazilian public health (Moraes et al., 2003) . In this country, Micrurus bites of all the genera follow the general pattern for treatment in snakebite cases, consisting in the protocol of applying a hyperimmune heterologous anti-elapid serum (made from equine immunization). The pool used for this process is obtained exclusively from Micrurus corallinus and Micrurus frontalis venoms (Tanaka et al., 2010; Corrêa-Netto et al., 2011) neglecting other species of equal importance and national occurrence.
The venom of the Micrurus genus follows the elapidic pattern in its biological actions, and its curare-mimetic actions are the most important cause of muscle paralysis and damage to respiratory function (Da Silva Jr. et al., 1991) . Preliminary studies have shown that there is occurrence of intense cardiotoxic and myotoxic activity (Weis and McIsaac, 1971) ; these activities were also described later, showing that there is variability in the proteins which constitute these venoms (Cecchini et al., 2005) . The range of actions and chemical compositions of venoms from the genus Micrurus is an adaptation to different habitats, which is an useful evolutionary tool for this species (Tanaka et al., 2010) . This variation in proteins and actions of the venom would enable snakes to have a predatorprey type selectivity making their diet specialized (Bernarde, 2011; Moreira et al., 2010) .
In Micrurus venom there is a considerable quantity of different toxins such as C-type lectins, natriuretic peptides precursors (NPP), L-amino acid oxidase (LAAO), metalloproteinases, Kunitz-type inhibitors, serine proteases, lysosomal acid lipase, hyaluronidase and alkaline phosphomonesterases (Corrêa-Netto et al., 2011; Leão et al., 2009) . The main toxins presents in Micrurus venoms are aneurotoxins 3FTx (three-finger toxins) and b-neurotoxins or phospholipase A 2 (PLA 2 ) with variable proportions in the proteome of poisons of various species being primarily responsible for toxicity (Castro et al., 2015) . The PLA 2 s are considered to be important toxins in snake venoms, especially in the Elapidae family.
In cases of accidents, PLA 2 acts directly causing changes in the permeability of cell membranes by cleaving the structural lipids at the 2-sn-phospholipid bond causing the release of lysophospholipids (Costa et al., 2008; Rossetto et al., 2006) . Those toxins are responsible for neurotoxic, myotoxic, and edematogenic activities (Castro et al., 2015) and in some species of Micrurus, act on blood coagulation, play an important role in homeostatic changes triggered by the venoms (Cecchini et al., 2005) . Therefore, the aim of this study is to promote the biochemical and functional characterization of crude venom from M. spixii, to purify and characterize one neurotoxic PLA 2 , in addition to demonstrating the microbicidal potential of this venom species.
Material and methods

Venoms and animals
The lyophilized crude venom of M. spixii was provided by Serpentarium Bioagents Batatais (SP), and acquired with the company Perubiotech EIRL™ of Huan aco (Huan aco State, Peru). These samples were kept frozen in a domestic freezer at À20 C. The use of mice is regulated and authorized by protocol n o 058/06-EAEC (UNESP-Botucatu). This study was licensed by CGEN (010627/ 2011-1) and IBAMA (27131-2).
Functional characterization
Phospholipase activity
A sample of 10 mL of M. spixii crude venom, a sample of 10 mL of Bothrops jararacussu crude venom and another containing the same volume of MsPLA 2 -I were used. Both fractions were analyzed for phospholipase activity with a colorimetric reaction using as a reagent 5 mg of 4N3OBA (4-nitro-3-octanoyloxy benzoic acid) that was solubilized in 5 mL of acetonitrile as previously described by Petrovic et al. (2001) . It was necessary to make buffer 1 (for phospholipase activity): 10 mM Tris, 100 mM NaCl, 10 mM CaCl 2 pH 8.0. Then, the dry aliquot of 4N3OBA was solubilized in 2 mL of buffer 1, with vigorous stirring and kept protected from light until use. For activity, in a flat-bottom plate 190 mL of 4N3OBA solution and 10 mL of sample were added to MsPLA 2 -I, with an initial concentration of 200 mg/mL. Immediately, the plates were introduced in the thermal spectrophotometer stabilized at 37 C, and the optical density (OD) was determined to be 425 nm at 1 min kinetic intervals for a period of 6 min. To calculate the activity it was considered that a 1 mM concentration solution has an OD of 2.54 AU.
Edematogenic activity
The edematogenic activity of M. spixii crude venom was initially established through the kinetics of edema activity as previously described by Soares et al. (2000) . Groups of 5 albino mice, males, weighing 18e22 g, were injected subcutaneously with 50 mL corresponding to 3.5 mg of venom diluted in 0.85% sterile saline in the right paw pad and the contralateral paw (control) was injected only with PBS. The thickness of the thighs were measured with a pachymeter (Mitutoyo, Japan, accurate to 0.01 mm) at the times of 15 min, 20 min and after this, checks were made at 10 min intervals up to 180 min. Edema was expressed as the difference between the thickness increases in the thighs of the experimental and control legs, divided by the values of the thickness of the legs measured at zero initial time, multiplied by 100.
Myotoxic activity evaluating the release of creatine kinase (CK)
Myotoxic activity was evaluated as previously described by Guti errez et al. (1986) , 5 albino male mice (Swiss) weighing between 28 and 32 g were used and 5 mg of M. spixii crude venom diluted in 0.5% sterile saline in a final volume of 50 mL was injected in the gastrocnemius muscle. A control group received only 10% PBS in a volume of 50 mL, and 0 h, 3 h and 6 h after application, blood was collected from the caudal vein and transferred to microhematocrit tubes and centrifuged for 3 min at 16,099.2Â g to separate the plasma. The amount of CK was then determined using 5 mL of plasma incubated for 2 min at 37 C with 0.5 mL of reagent according to the kinetics of CK-NAC Labtest protocol. The activity was expressed as U/L, with one unit corresponding to the production of 1 mmol NADH/minute. Baseline plasma CK mice were considered to be the "zero" reference value.
Myographic study
Mice were killed by exsanguination after cervical dislocation. The phrenic nerve-diaphragm muscle preparation was prepared as previously described by Bülbring (1946) removed and mounted vertically under a tension of 5 g in a conventional isolated organ bath chamber containing 15 mL of physiological solution of the following composition (mmol/L): NaCl, 135; KCl, 5; MgCl 2 , 1; CaCl 2 , 2; NaHCO 3 , 15; Na 2 HPO 4 , 1; glucose, 11 (Ringer). This solution was bubbled with carbogen (95% O 2 and 5% CO 2 ) and kept at 35 ± 2 C. The preparation was attached to an isometric force transducer (Grass, FT03) coupled to a signal amplifier (Gould Systems, . The recordings were made on a computer through a data acquisition system (Gould Sytems, Summit ACQuire and Summit DataViewer). The preparation was stabilized for at least 45 min.
Then, the M. spixii venom (5 mg/mL) or its MsPLA 2 (5 mg/mL) were administered to the organ bath. Indirect contractions were evoked by supramaximal strength pulses (0.2 Hz; 0.5 ms; 3 V) applied on the phrenic nerve by a suction electrode. Direct contractions were evoked by supramaximal pulses (0.2 Hz; 5 ms; 13 V), through a bipolar electrode positioned on opposite sides of the muscle. Pulses were delivered by an electronic stimulator (Grass S88K). The amplitude of indirect and direct twitches was measured during 360 and 390 min respectively. Experiments of direct contractions were performed in the presence of pancuronium bromide (2 Â 10 À6 M).
Antiplasmodial activity
The in vitro antiplasmodial activity of M. spixii crude venom was evaluated against Plasmodium falciparum (clone W2, chloroquine resistant) blood stage cultures, cultured as previously described (Trager and Jensen, 1976) . All assays were started with ring stagesynchronized cultures with 5% sorbitol according to Lambros and Vanderberg (1979) . Parasites were washed and mixed with RPMI 1640 (with 10% of albumax) and uninfected erythrocytes to obtain 0.05% parasitemia and 1.5% hematocrit. The crude venom of M. spixii was diluted with RPMI 1640 in order to obtain the desired test concentrations. Serial twofold dilutions (seven concentrations and one drug-free control) of the sample (20 mL/well) were dispensed into standard 96-well microculture plates and 180 mL of infected erythrocytes culture were added. The assay was done in triplicate, negative control cultures received only RPMI and control positive cultures received chloroquine (CQ), an antimalarial drug according to Penna-Coutinho et al. (2011) . The plates were incubated for 72 h in a gas mixture (5% CO 2 , 5% O 2 , 90% N 2 ) at 37 C. They were subsequently frozen-thawed twice to obtain complete hemolysis. The anti-P. falciparum effects of the compounds were measured through an immunoenzymatic test with specific monoclonal antibodies (MPFM ICLLAB-55A
® and MPFG55P ICLLAB ® , USA) to a parasite histidine-rich protein (HRPII) commercially available, and performed as described (Noedl et al., 2002) . HRPII quantification was read at 450 nm in a spectrophotometer (Spectra Max 340PC 384 , Molecular Devices). The half-maximal drug inhibitory response (IC 50 ) was estimated by curve fitting, using software from the OriginLab Corporation (Northampton, MA, USA). The results were then compared to parasite growth in the drug-free controls.
Cytotoxic effect
The cytotoxicity of M. spixii crude venom was verified using increasing concentrations of these venoms inoculated in cultures of human hepatoma cells (HepG 2 ) according to Calvo-Calle et al. (1994) . The confluent cell monolayer was prepared as described by Denizot and Lang. (1986) . The compounds were added to each well at various concentrations (1e200 mg/mL) and incubated for 24 h at 37 C in a humidified atmosphere (5% CO 2 ). Next, 20 mL of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] solution (5 mg/mL) was added to each well and the plates were incubated for 3 h. The supernatant was carefully removed and 100 mL of DMSO was added with stirring to solubilize the formazan crystals formed. The optical density (O.D.) was determined between 570 and 630 nm (background) (Spectra Max 340PC 384 , Molecular Devices). Cell viability was expressed as a percentage of control absorbance in untreated cells after subtracting the appropriate background. The minimum lethal dose for 50% of the cells (MLD 50 ) was determined as previously described (Madureira et al., 2002) . The selectivity index (SI) was calculated as the ratio between cytotoxicity against hepatoma cells (MLD 50 ) and anti-P. falciparum activity (IC 50 ). An SI greater than 10 was considered non-toxic (B ezivin et al., 2003) .
2.2.7. Antileishmanial activity Leishmania (Leishmania) amazonensis PH8 strain promastigotes (IFLA/BR/67/PH8) were routinely cultured at 23 C in RPMI 1640, supplemented with 10% inactivated fetal bovine serum (FBS), 20 mmol L-1 Hepes (N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid), and 50 mg/mL of gentamycin and subcultured every 96 h.
The cytotoxity of M. spixii crude venom was determined using the viability of promastigote forms of L. amazonensis with an MTT assay (Pal et al., 2011) . For these experiments, promastigotes in the stationary phase were seeded at 5 Â 10 5 parasite/100 mL/well on a 96-well plate in complete RPMI 1640 medium with progressive concentrations of venoms (0.78e6.25 mg/mL). The venom to be tested was dissolved in PBS. Pentamidine (5 mg/mL) was used as a reference of an antileishmanial agent. Promastigotes were incubated at 23 C for 72 h. Then, 10 mL of an MTT solution (5 mg/mL in phosphate buffered saline) was added to each well and incubated for more 4 h at 23 C, then centrifuged at 8000 Â g for 10 min. In order to dissolve the formazan crystals formed, each well received 100 mL of DMSO and was incubated for 1 h at room temperature.
The absorbance was immediately read at 540 nm in a spectrophotometer. Each concentration was screened in quadruplicate and experiments were repeated three times. The results are expressed as the percentage of cytotoxicity which was determined by the formula 1 e [(absorbance of treated cells e absorbance of blank)/ (absorbance of control cells e absorbance of blank)] Â 100. The 50% inhibitory concentration (IC 50 ) was calculated by the sigmoid doseeresponse analysis statistics, using Origin software, which considered the means of three performed assays.
Statistical analysis
Data were expressed as mean ± standard error of mean (SEM). Phospholipase activity was analyzed by the non-parametric test of KruskaleWallis. The remaining results were submitted to parametric statistical analysis by the Student's t test, for comparing two groups, and the variance analysis (ANOVA) supplemented by the TukeyeKramer test, for comparing more than two groups. In all cases, the significance level was 5% (p 0.05).
Biochemical characterization 2.3.1. Reverse phase chromatography (HPLC)
The chromatography was adapted from the method previously described by Calvete et al. (2011) where a sample with 5 mg of crude lyophilized M. spixii venom was diluted in 1.0 mL of solubilizing solution consisting of 95% trifluoroacetic acid (TFA) 0.1% and 5% acetonitrile (ACN) 99.9%. The insoluble material was removed by centrifugation at 13,000Â g for 10 min at room temperature. The venom was fractionated using a Discovery 100 RP C18 column (250 Â 4 mm, 5 micron particle size) previously equilibrated with 0.1% TFA (eluent A) and eluted under a segmented gradient of 99.9% ACN and 0.1% TFA (eluent B) at 5% for 10 min, 5e15% for 20 min, 15e45% for 120 min, 45e70% for 20 min, and 70e100% for 10 min, under a flow rate of 1.0 mL/min. Elution was monitored at 215 and 280 nm and the fractions collected manually, dried in a Speed-Vac and stored in a À20 C freezer.
Electrophoretic analysis on SDS-PAGE
A sample of crude venom and another containing MsPLA 2 -I were applied on SDS-PAGE 12.5%. The electrophoretic conditions were the same as those established by Laemmli (1970) . The proteins in the gel were fixed using a solution containing 12% acetic acid (v/v) 
Electrophoretic 2D SDS-PAGE analysis
A 30 mL sample of M. spixii crude venom was solubilized in 200 mL rehydration solution containing 7 M urea, 2 M thiourea, 2.0% CHAPS (m/v), 0.5% immobilized pH gradient buffer (IPG buffer ® ) (v/ v) and 1.0% bromophenol blue (m/v); and applied to 7 cm polyacrylamide strips with a pH gradient of 3.0e10.0 immobilized nonlinearly (Immobiline DryStrip ® ). Isoelectric focusing was performed in an IPGphor III System (GE Healthcare Life Science) according to the manufacturer's instructions. After isoelectric focusing, the sample was reduced and alkylated and the strip positioned in the upper portion of the 12.5% SDS-PAGE gel (m/v) to perform the second dimension (15 mA, 90 min). The gel was fixed, stained and discolored as described above in item 2.3.2. The gel's image was obtained with the aid of an Image Scanner III © and analyzed with the aid of IQTL software (GE Healthcare Life Science).
Mass spectrometry
Mass spectrometry was performed in equipment MALDI (desorption ionization-assisted laser array), with two TOF analyzers (AXIMA TOF 2 Shimadzu Biotech) operating in linear mode using a saturated solution of sinapinic acid as the ionization matrix. The molecular mass of the sample was determined by comparison to external standards of proteins.
N-terminal sequencing
The sequencing of MsPLA 2 -I's primary structure isolated from the M. spixii venom was performed in an automatic microsequencer PPSQ-33A (Shimadzu), which uses the chemical process of sequencing by N-terminal cleavage derivative method developed by Edman as described by Gray et al. (1972) . A search for similar sequences was performed in UniProtKB and NCBI databases using the BLAST program and multiple alignments using the CLUSTALW2 program.
Results
M. spixii venom presented greater phospholipasic activity than B. jararacussu crude venom ( Fig. 2A) , when it was injected in mice paws it was able to induce edema after 20 min (Fig. 2B) , and in the myotoxic assay the venom caused significantly increased plasma CK (Fig. 2C) . Additionally, M. spixii crude venom presented microbicidal potential with activity against P. falciparum and antitumoral potential with a cytotoxic effect against human hepatoma cells (HepG2) ( Table 1) .
Regarding the anti-Plasmodium positive control Chloroquine had an IC 50 of 0.03 mg, and the venom of M. spixii had an IC 50 of 0.78 mg, demonstrating plasmonicidal action. Fig. 3 shows the cytotoxic effect of M. spixii venom with an IC 50 of 1.24 mg/mL against L. amazonensis when compared with the positive control Pentamidine.
Bidimensional electrophoresis of M. spixii venom demonstrated a concentrated protein/peptide profile mainly in the pH range between 4 and 8 with molecular weights less than 15 kDa (Fig. 4) .
The chromatogram of M. spixii venom demonstrated a profile with more than 14 main fractions of proteins/peptides (Fig. 5A) , with the fraction corresponding to the phospholipase A 2 , named MsPLA 2 -I, having been eluted with 21% of solvent B. This enzyme was re-chromatographed under the same conditions (Fig. 5B) and presented a molecular weight of approximately 12 kDa, by SDS-PAGE (Fig. 5C) .
MsPLA 2 -I was submitted to mass spectrometry demonstrating a Mw of 12,809.40 Da (Fig. 5D ) and the N-terminal sequencing of 60 amino acid residues demonstrated the presence of the amino acid aspartic acid at position 49 (Asp49), which is characteristic of enzymatically active phospholipases (Fig. 6) . In fact, MsPLA 2 -I presented phospholipase activity against 4N3OBA, being most stable between pHs 6 and 8, and at temperatures from 37 to 70 C (Fig. 7) . The sequential analysis revealed 80% similarity to the PLA 2 of Micrurus altirostris (Table 2) .
M. spixii venom (5 mg/mL) and MsPLA 2 -I (5 mg/mL) induced time-dependent inhibition of both direct and indirect evoked twitches in mice neuromuscular preparation (Fig. 8) . However, in the case of the M. spixii venom, the time for 50% blockade (t50) of direct contractions (180 ± 7 min, n ¼ 5) was not significantly different from that of the indirect ones (204 ± 9 min, n ¼ 5). In contrast, the t50 of MsPLA 2 -I for direct contractions (248 ± 13 min, n ¼ 4) was significantly higher than that of indirectly evoked twitches (89 ± 6 min, n ¼ 4). Under indirect stimulation, the blockade was preceded by a slight increase in the twitch-tension during the first 15e30 min after venom addition (Fig. 8A) . The muscle paralysis induced by both the venom and MsPLA 2 -I was not reversed when the preparations were washed with toxin-free physiological solution by at least 120 min (data not shown).
Discussion
M. spixii venom presented high phospholipasic activity when compared with B. jararacussu venom. This last venom was chosen as a positive comparison since it characteristically presents high phospholipase content (Corrêa et al., 2006) .
The venom of this Amazonian coral snake presented significant kinase during 6 h after the inoculation of 50 mL (5 mg) of M. spixii crude venom (CV) in the right mouse gastrocnemius muscle, 10% PBS (50 mL) was inoculated in the control group to compare the variation of plasmatic concentration of the enzyme, which indicates damage to the musculature. The basal values of plasmatic CK for mice were considered to be a reference value of "zero". The values represent the mean ± SD (n ¼ 5) (p < 0.05). a SI (Selectivity Index) was obtained through the ratio between cytotoxicity against hepatoma cells (MLD 50 ) and anti-Plasmodium falciparum activity (IC 50 ).
Fig. 3. Cellular viability using the MTT method where different concentrations of
Micrurus spixii venom (6.25e0.78 mg/mL) were added to each well with cells infected with promastigote forms of L. amazonensis. The reading was done after 72 h. The drug Pentam ® was used as a positive leishmanicidal control. IC 50 ¼ 1.24 mg/mL. The values represent the mean ± SD (n ¼ 5) (p < 0.05). *p < 0.05, Pentam compared to 3.12 mg/mL; ***p < 0.001, Pentam compared to 1.56 and 0.78 mg/mL. edematogenic activity in mice. Cecchini et al. (2005) observed a differential edematogenic effect when this action was compared among several Micrurus species. When the mice inoculation was done with Micrurus surinamensis and Micrurus nigrocinctus venoms, significantly higher edema compared to the negative control was observed. Diverse studies have been done to evaluate the effect of Micrurus crude venom in causing edema. The experimental models vary significantly including: domestic felines (Felis catus) (Weis and McIsaac, 1971) , cattle (Bos taurus) and horses (Equus caballus) (Bolaños et al., 1975) , mice (Guti errez et al., 1986; Renjifo et al., 2012; de Roodt et al., 2012) , as well as the important report of the accident in a human by Pardal et al. (2010) , with low intensity and transient edema. In those animal experimental models and human patients, there were variations in the edematogenic responses, varying from nonexistent to low intensity, wherein just a few Micrurus species are capable of inducing relevant edema, such as that produced by M. spixii. In many of the studies cited above, although there was no edema or if there was, it was not intense, the deaths of many animals occurred in all the experimental models tested. These results suggest that the different organisms tested and the variability in composition of Micrurus venoms were responsible for variable edematogenic responses.
The venom of M. spixii was capable of inducing myotoxicity evaluated by the release of creatine kinase (CK) in mice plasma, after the experimental envenoming. The intensity of release of CK was observed after the inoculation in the gastrocnemius muscle of mice with the crude venom and with PLA 2 s isolated from M. nigrocinctus (Alape-Gir on et al., 1999; Goularte et al., 1995) . Le on et al. (1999) also verified the significant increase in the release of CK in mice inoculated with M. nigrocinctus venom and intense myonecrotic activity.
In their study, de Roodt et al. (2012) compared the induced release of CK with the application in the anterior tibial muscle in Wistar rats. Venoms from M. altirostris, M. surinamensis, Micrurus fulvius, M. nigrocinctus, Micrurus balyocoriphus, Micrurus pyrrhocryptus were used for inoculation in this experiment. All the venoms presented PLA 2 activity, and M. nigrocinctus had the greatest and most significant result for both PLA 2 action as well as CK release.
When tested in mice phrenic-diaphragm preparation, M. spixii venom simultaneously inhibited the direct and indirect contractions without significantly different t 50 . This finding indicates that the neuromuscular process is not selectively affected by the venom and that a direct effect on muscle fibers may contribute to the paralysis. Supporting this hypothesis, we observed that M. spixii venom presents a slow blockade of indirect twitches (t 50 ¼ 204 ± 9 min, n ¼ 5) compared to the highly neurotoxic venom of Micrurus leminiscatus carvalhoi that completely inhibits the neuromuscular transmission in about 50 min, at the same experimental conditions (Cecchini et al., 2005) .
Furthermore, the neuromuscular profile effect of M spixii venom is similar to that described for M. nigrocinctus which presents summation of neurotoxic and myotoxic activities (Goularte et al., 1995) . The myotoxic effect of M. spixii venom was also demonstrated in this study by the pronounced release of CK in vivo. Additionally this venom presented elevated phospholipasic activity which is a characteristic commonly found in other Micrurus myotoxic venoms, such as M. nigrocinctus and M. fulvius (de Roodt et al., 2012) . Despite the fact that myotoxicity is not a frequent manifestation of Micrurus snakebites envenoming, an increase in plasmatic CK activity has been reported in human envenomation by some Micrurus species and should be considered in the overall toxicity of these venoms (de Roodt et al., 2012) .
Similarly to the whole venom, the isolated MsPLA 2 -I induced the blockage of both direct and indirect twitches. However, the t 50 of indirect contractions was significantly lower than that of the direct ones, characterizing the occurrence of neurotoxic and myotoxic activities with different time courses. The initial facilitation of the indirect twitches' amplitude induced by MsPLA 2 -I could be attributed to the increase in acetylcholine release that characteristically precedes the blockade induced by presynaptic neurotoxic PLA 2 , possibly as a result of the nerve terminal depolarization (Goularte et al., 1995) .
In addition, MsPLA 2 -I also expresses myotoxic activity evidenced by the slower blockade of direct contractions that may result from the destabilization of the muscle fiber membrane leading to cell depolarization and unexcitability. The presence of neurotoxic and/or myotoxic PLA 2 have been detected in variable quantities in several Micrurus venoms, such M. corallinus, M. nigrocinctus and M. fulvius, (Alape-Gir on et al., 1996; de Oliveira et al., 2003; Goularte et al., 1995; Possani et al., 1979) . In this study, it was demonstrated that MsPLA 2 -I represents only about 5% of the whole M. spixii venom and this may explain the mild neurotoxic activity of this venom when compared with others.
The neuromuscular blocking mechanism is due to synergy between the actions of a-neurotoxins and svPLA 2 s. The a-neurotoxins interact with a specific site in the extracellular domain (ECD) of the postsynaptic nicotinic receptor (nAchR) by direct competition with acetylcholine (Ach) at the binding site (Blacklow et al., 2011; Oliveira et al., 2000) . The svPLA 2 s bind elsewhere and do not compete with the Ach receptor structure directly, but prevent the conformational change of the ion channel that would allow for the passage of the ion and its normal operation (Purohit and Auerbach, 2013; Vulfius et al., 2014) . Understanding how MsPLA 2 -I interacts with post-synaptic nAchRs is essential to characterize its action as a toxin and understand the physiological changes caused by the venom. Elapid PLA 2 s interact with the abgd subunits of nAchRs, which may vary greatly in the receptor interaction site and the toxin itself, since the bsheets and the His48-Asp49 regions of groups I and II svPLA 2 s are directly involved in these interactions with proteins and other molecules (Faure et al., 2007; Yadava et al., 2013) . The higher intensity interaction was between the PLA 2 and the a subunit and with some links to the contiguous g subunit being that this link between toxin and subunits made at this intersection is characteristic of the interaction of a PLA 2 with an nAchR (Vulfius et al., 2014) . This same binding mechanism is also used by PLA 2 s to block other ion channels, such as acid-sensitive ion channels (Acid sensing ion channels, ASICs) responsible for the nociceptive mechanism in mammals (Baconguis et al., 2014) .
Cytotoxic activity against human hepatoma cells (HepG 2 ) was observed in M. spixii crude venom, with the smallest toxicity towards hepatic cells (MDL 50 > 200 mg). Studies of this type using Micrurus crude venom or toxins are practically nonexistent and the most similar study was a project with elapid and viperid venoms by Queiroz (2012) with crude venom from Acanthophis antarcticus (Elapidae) Agkistrodon bilineatus (Viperidae) Notechis ater niger (Elapidae) and Pseudonaja textilis (Elapidae) snakes against murine melanoma cells (B16-F10) and normal fibroblast lines L929, obtaining significant cytotoxicity upon tumor cells.
As a comparison, the inter-relationship between the presence of phospholipase activity and cytotoxic action of various venoms and PLA 2 s isolated from viperids must be cited. Several studies were done with human leukemic T cell lines (JURKAT), tumoral cells from mice (EAT line), human melanoma (IGR39) and fibrosarcoma HT1080 (Costa et al., 2008; Zouari-Kessentini et al., 2013) . It may be suggested, that phospholipase A 2 activity is directly correlated to antitumoral activity in elapid and viperid venoms, since this toxin is responsible for directly interfering with the mechanisms of angiogenesis, cell proliferation and inducing tumor regression by stimulating apoptotic mechanisms in tumor cells (Calderon et al., 2014; Rodrigues et al., 2009) .
The anti-plasmodial activity of M. spixii venom was significantly the best among the snake venoms tested (results not shown) only being less effective than Chloroquine, the anti-malarial drug used as a positive control. There are no other antiplasmodial activity experiments using Micrurus venoms. Quintana et al. (2012) tested two PLA 2 s isolated from Crotalus durissus cumanensis venom against P. falciparum, verifying the intense anti-plasmodial activity of these toxins. Both with fractions characterized as PLA 2 as well as with the total crude venom of Bothrops asper, Castillo et al. (2012) demonstrated intense anti-plasmodial activity, and the fraction with the greatest PLA 2 activity was the fraction that had the greatest parasiticidal efficacy against P. falciparum in their experiment. Costa et al. (2008) . The phospholipase activity of MsPLA 2 -I on the substrate 4N3OBA (4-nitro-3-octanoyloxy benzoic acid) was evaluated with a colorimetric reaction. The reading was done when there was a variation in pH (A) and temperature C (B). The asterisks (*) show in which range of temperature or pH the phospholipase activity was significantly less in relation to the others. The results are presented as mean ± SD (n ¼ 3) of two individual experiments (p < 0.05). The chromatographic pattern of the crude venom of M. spixii and MsPLA 2 -I was as expected for the genus Micrurus and is similar to that found in other studies done comparing this species with others of its genus (Chac on et al., 2012; Da Silva Jr. et al., 1991; Remuzgo et al., 2002; Rey-Súarez et al., 2011) . In electrophoresis, the masses present proteins between 10 and 15 kDa, agreeing with the results described by Alape-Gir on et al. (1999) , which made a comparison between the results of electrophoresis of venoms of 15 species of the genus Micrurus, including M. spixii and obtained results within the same range of molecular weight. It is important to note that these bands of low molecular weight, especially localized below 14 kDa, are quite clear and are found in other genera of the Elapidae family (Ciscotto et al., 2011; Dokmetjian et al., 2009; Nawarak et al., 2003) .
With an Mw of 12,809.40 Da MsPLA 2 -I presented a mass according to that expected for a Micrurus PLA 2 being between 12 and 18 kDa (Murakami and Kudo, 2001; Oliveira et al., 2008; Rey-Súarez et al., 2011) . The fragment of 60 amino acids obtained by the sequencing of MsPLA 2 -I when aligned with sequences of PLA 2 s of other Micrurus species presented 80% similarity with the enzyme from M. altirostris (Ciscotto et al., 2011) . It was observed in the alignment, the presence in all the sequences of the amino acids Histidine in position 48 and Aspartic acid in position 49 (His48-Asp49), characteristic of enzymatically active PLA 2 s. Another important finding is a Cysteine at position 11 (Cys11) in MsPLA 2 -I and in all the other PLA 2 s the presence of Cys11 and Cys77 which form disulfide bridges characteristic of group I PLA 2 s. This is also a structural marker that allows for the classification of MsPLA 2 -I as an svPLA 2 belonging to elapids, since in group II PLA 2 s this disulfide bridges is changed to Cys51-Cys133. There is an important region between positions 52 and 65 called the elapidic loop that is exclusive of group I PLA 2 s, where there are 13 variable amino acids. In that region a Tyrosine in position 52 (Tyr52) and an Alanine in position 55 (Ala55) in all sequences. Among five aligned Micrurus PLA 2 s, three PLA 2 s and MsPLA 2 -I share the sequence Threonine, Valine and Hystidine in positions 57, 58 and 59. It is important to observe that, in the region corresponding to the elapidic loop, only 8 amino acids were found in sequence of MsPLA 2 -I (between positions 52 and 60) and among them, 5 amino acids are in the same position as other PLA 2 s sequenced, and those amino acids appear in key positions to classify MsPLA 2 -I as a group I phospholipase (Arni and Ward, 1996; Burke and Dennis, 2009; Six and Dennis, 2000) .
MsPLA 2 -I also had its PLA 2 activity tested in conditions of varied pHs and temperatures, demonstrating moderate thermo-pHstability, with significant reduction only at pHs 4.0 and 9.0 and temperatures above 80 C. In a similar study comparing viperid and elapid venoms, Bottrall et al. (2010) also observed protein stability, especially in elapid venoms, since when they tested the myotoxicity against bovine musculature, even in extremely alkaline conditions, there was still significant enzymatic activity. Viperid PLA 2 s show a greater limitation in maintaining their phospholipasic activity when they are submitted to variations in pH and temperature, showing maximum activity only within the narrow range of 35 and 40 C and pHs between 7.0 and 8.0 (Heleno et al., 2013; Huancahuire-Vega et al., 2014) . This limitation of activity in function of temperatures and pHs near physiological levels, seems to be characteristic of group II PLA 2 s (viperid) and it is also observed that human PLA 2 s lose stability and activity outside of this range (Leidy et al., 2006) .
The biochemical characterization and the biological activities of the crude venom and of MsPLA 2 -I presented in this study showed some new results such as the antiparasitic and antitumoral potential for the venom of the genus Micrurus. These results make M. spixii venom promising compounds with potential biotechnological use.
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